Posterior urethral stenosis: a comparative review of the guidelines Behzad AbbasiNathan M. ShawBenjamin N. Breyer Invited Review Open access 26 August 2022 Pages: 2591 - 2600
Fluoroscopy screening time and radiation dose during complete supine percutaneous nephrolithotomy Siavash FalahatkarPurya HaghjooEhsan Kazemnezhad Original Article 06 September 2022 Pages: 2601 - 2607
Survival with novel hormonal therapies in patients with nonmetastatic castration-resistant prostate cancer: indirect comparison of three randomized phase-III trials Melania RivanoLuca CancanelliAndrea Messori Original Article 09 September 2022 Pages: 2609 - 2615
A systematic review of treatment options for post-prostatectomy incontinence Alexander CanningNicholas RaisonKamran Ahmed Original Article Open access 15 September 2022 Pages: 2617 - 2626
Nomogram based on baseline clinicopathological characteristics for predicting bladder cancer-specific survival to neoadjuvant chemotherapy in muscle-invasive bladder cancer Albert FontMontserrat DomenechAnna Esteve Original Article 15 September 2022 Pages: 2627 - 2634
Functional and surgical outcomes after phalloplasty in cis men Agate EscoffierNicolas Morel-JournelPaul Neuville Original Article 16 September 2022 Pages: 2635 - 2640
Evaluating the association between food insecurity and risk of nephrolithiasis: an analysis of the National Health and Nutrition Examination Survey Benjamin W. GreenKevin LabagnaraAlexander C. Small Original Article 20 September 2022 Pages: 2641 - 2647
Does the 5-item Frailty Index predict surgical complications of endoscopic surgical management for benign prostatic obstruction? An analysis of the ACS-NSQIP Muhieddine LabbanNicola FregoQuoc-Dien Trinh Original Article 20 September 2022 Pages: 2649 - 2656
Radical nephroureterectomy for UTUC conferred survival benefits irrespective of age and comorbidities Jeremy Yuen-Chun TeohChi-Fai NgJean de la Rosette Original Article 20 September 2022 Pages: 2657 - 2665
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? Giuseppe FallaraAlessandro LarcherUmberto Capitanio Original Article 20 September 2022 Pages: 2667 - 2673
Determining the threshold of acute renal parenchymal damage for intrarenal pressure during flexible ureteroscopy using an in vivo pig model Matthew S. LeeBret A. ConnorsAmy E. Krambeck Original Article 22 September 2022 Pages: 2675 - 2681
Assessing the need for systematic biopsies in addition to targeted biopsies according to the characteristics of the index lesion at mpMRI. Results from a large, multi-institutional database Francesco BarlettaElio MazzoneAlberto Briganti Original Article 23 September 2022 Pages: 2683 - 2688
Value of magnetic resonance imaging/ultrasound fusion prostate biopsy to select patients for focal therapy Roman GanzerAlexander MangoldWolfgang Brummeisl Original Article 24 September 2022 Pages: 2689 - 2694
Perineural invasion as predictor of biochemical recurrence in prostate cancer following open radical prostatectomy: a single-center experience Mladen StankovicLaura WolffBastian Schumacher Original Article 24 September 2022 Pages: 2695 - 2700
Development of an automated laser drilling algorithm to compare stone ablation patterns from different laser pulse modes Nikta Rezakahn KhajehTimothy L. HallWilliam W. Roberts Original Article 27 September 2022 Pages: 2701 - 2705
Multicenter evaluation of neoadjuvant and induction gemcitabine–carboplatin versus gemcitabine–cisplatin followed by radical cystectomy for muscle-invasive bladder cancer Sarah M. H. EinerhandAnna J. BlackLaura S. Mertens Original Article 28 September 2022 Pages: 2707 - 2715
Impact of COVID-19 pandemic on diagnosis and surgical management of common urological conditions: results from multi-institutional database analysis from the United States Mohammad HoutMaria Camila Suarez ArbelaezHemendra N. Shah Original Article 01 October 2022 Pages: 2717 - 2722
Percentage Gleason pattern 4 and PI-RADS score predict upgrading in biopsy Grade Group 2 prostate cancer patients without cribriform pattern Margaretha A. van der SlotNeslisah SeyrekGeert J. L. H. van Leenders Original Article Open access 03 October 2022 Pages: 2723 - 2729
Incidence and risk factors for postoperative urinary incontinence after various prostate enucleation procedures: systemic review and meta-analysis of PubMed literature from 2000 to 2021 Mohammad HoutAaron GurayahHemendra N. Shah Original Article 04 October 2022 Pages: 2731 - 2745
Influence of holmium laser enucleation of the prostate on erectile function: results of a multicentric analysis of 235 patients Maxime DeslandesClément KleinGrégoire Robert Original Article 04 October 2022 Pages: 2747 - 2754
Adherence to guideline recommendations in the management of upper tract urothelial carcinoma: an analysis of the CROES–UTUC registry Joyce BaardShahrokh F. ShariatPilar Laguna Original Article 05 October 2022 Pages: 2755 - 2763
Axumin (18F-Fluciclovine) PET imaging in men exhibiting no clinically significant cancer on initial negative biopsy of PI-RADS 4 and 5 regions of interest Ezequiel BecherShawn KarlsHerbert Lepor Original Article 05 October 2022 Pages: 2765 - 2770
Changes in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (Radical Nephroureterectomy Outcomes (RaNeO) Research Consortium) Alessandro TafuriMichele MarchioniAlessandro Antonelli Original Article Open access 06 October 2022 Pages: 2771 - 2779
The association between prostatitis and risk of prostate cancer: a National Health Insurance Database study Gyoohwan JungJung Kwon KimSung Kyu Hong Original Article 06 October 2022 Pages: 2781 - 2787
Perioperative outcomes following robot-assisted partial nephrectomy in elderly patients Gopal SharmaMilap ShahGagan Gautam Original Article 06 October 2022 Pages: 2789 - 2798
Efficacy of TAC-302 for patients with detrusor underactivity and overactive bladder: a randomized, double-blind, placebo-controlled phase 2 study Masaki YoshidaMomokazu GotohOsamu Yamaguchi Original Article Open access 07 October 2022 Pages: 2799 - 2805
Bladder paraganglioma: basic characteristics and new perspectives on perioperative management Taonong CaiJiangli LuYunlin Ye Original Article 07 October 2022 Pages: 2807 - 2816
Identification of LAT/ZAP70 characterized immune subtypes of prostate cancer Jianpeng YuWenlong GaoYuanjie Niu Original Article 07 October 2022 Pages: 2817 - 2824
Comment on “Role of prehabilitation following major uro‑oncologic surgery: a narrative review” Christian BeilsteinPatrick Y. WuethrichDominique Engel Letter to the Editor 01 September 2022 Pages: 2825 - 2826
Treatment options for low-risk prostate cancer Yuxuan SongTao Xu Letter to the Editor 13 September 2022 Pages: 2827 - 2828